Inari Medical develops innovative devices for treating venous diseases, enhancing patient outcomes through minimally invasive technologies.

Inari Medical (NASDAQ:NARI) focuses on developing, manufacturing, and marketing devices specifically aimed at the treatment of venous diseases. Its portfolio majorly includes innovative products designed for the interventional treatment of venous thromboembolism (VTE) and varicose veins. The company's mission revolves around enhancing patient outcomes by providing minimally invasive technologies that effectively address venous issues. Among its notable projects, the ClotTriever and FlowTriever systems stand out for their effectiveness in clot removal procedures, showcasing Inari Medical's commitment to advancing venous disease treatment. The objective of Inari Medical is to continue expanding its product offerings and market reach, ultimately aiming to improve the quality of life for patients suffering from debilitating venous conditions.
GET YOUR GRAFA EDGE NOW
Sign up free to follow this company
We'll switch on a 30-day Edge trial as a welcome gift